Programmed death ligand 1 expression in prostate cancer cells is associated with deep changes of the tumor inflammatory infiltrate composition

Manuel Scimeca, Rita Bonfiglio, Nicoletta Urbano, Chiara Cerroni, Lucia Anemona, Manuela Montanaro, Sara Fazi, Orazio Schillaci, Alessandro Mauriello, Elena Bonanno

Research output: Contribution to journalArticle

Abstract

BACKGROUND: The main aim of this study was to investigate the putative correlation between the composition of intratumoral inflammatory infiltrate and the expression of programmed death ligand 1 (PD-L1) by prostate cancer cells. In addition, we evaluated the correlation between the expression of PD-L1 and PTX3.

METHODS: We enrolled 100 patients from which we collected one surgical sample each. Paraffin serial sections were obtained to perform histological classifications and tissues microarray construction. Serial tissues microarray paraffin sections were also used for PD-L1 analysis and intratumoral inflammatory infiltrate characterization (CD4, CD8, CD57, CD3, PD1, PSGL-1, TIGIT, CD20, CD38, CD68, CD163, and PTX3) by immunohistochemistry .

RESULTS: Our result showed a significant increase of the number of both PD-L1 and PTX3 positive cells in prostate tumors respect to benign lesions. Inflammatory infiltrate of PD-L1 positive prostate cancer lesions was characterized by a decrease of both PD1 positive lymphocytes and tumor-infiltrated macrophages, mainly M2 subpopulation. Also, PTX3 expression showed an inverse correlation with the number of PD-L1 positive prostate cancer cells.

CONCLUSIONS: If confirmed, our data could be useful to predict the variations of the inflammatory population related to PD-L1 expression in prostate cancer. This can lay the foundation to establish therapeutic protocols able to inhibit the PD-L1 activity and, at the same time, to reactivate the antitumor inflammatory process.

Original languageEnglish
Pages (from-to)297.e19-297.e31
JournalUrologic Oncology
Volume37
Issue number5
DOIs
Publication statusPublished - May 2019

Fingerprint Dive into the research topics of 'Programmed death ligand 1 expression in prostate cancer cells is associated with deep changes of the tumor inflammatory infiltrate composition'. Together they form a unique fingerprint.

  • Cite this

    Scimeca, M., Bonfiglio, R., Urbano, N., Cerroni, C., Anemona, L., Montanaro, M., Fazi, S., Schillaci, O., Mauriello, A., & Bonanno, E. (2019). Programmed death ligand 1 expression in prostate cancer cells is associated with deep changes of the tumor inflammatory infiltrate composition. Urologic Oncology, 37(5), 297.e19-297.e31. https://doi.org/10.1016/j.urolonc.2019.02.013